CAS RN: 2091142-15-1
Methyl 3-Bromo-5-cyclopropylisoxazole-4-carboxylate
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g, 1g, 5g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2091142-15-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Shenzhen
Inquiry
1g
≥95%
0
Out of Stock
Beijing
Inquiry
5g
≥95%
0
Out of Stock
Shanghai
Inquiry
2091142-15-1 / methyl 3-bromo-5-cyclopropyl-1,2-oxazole-4-carboxylate
Standard CAS: 2091142-15-1
Multi CAS: No
Basic Information
copy
CAS
2091142-15-1 copy
Multi CAS
No copy
Molecular Formula
C8H8BrNO3 copy
Molecular Weight
246.060000 copy
Exact Mass
244.968760 copy
SMILES
COC(=O)C1=C(ON=C1Br)C2CC2 copy
InChI
InChI=1S/C8H8BrNO3/c1-12-8(11)5-6(4-2-3-4)13-10-7(5)9/h4H,2-3H2,1H3 copy
InChIKey
IHZHYSZTPYOQLY-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
13 copy
Aromatic heavy atom count
5 copy
Fraction Csp3
0.5 copy
Rotatable bonds
2 copy
H-bond acceptors
4 copy
Molar refractivity
47.52 copy
TPSA
52.33 copy
LogP / Solubility
WLOGP
2.1 copy
MLOGP
1.85 copy
XLogP3
1.8 copy
Consensus LogP
1.92 copy
Log S (ESOL)
-2.84 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-3.09 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.24 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.73 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy